CD4-specific CAR T Cells (CD4 CAR T Cells) for Relapsed/Refractory T Cell Malignancies
Condition: Relapsed/Refractory, High Risk Multiple Myeloma Intervention: Biological: CD4 CAR T cells Sponsors: iCell Gene Therapeutics; iCAR Bio, China Recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials